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Introduction
From 2011 to date, there are increasing detections of
carbapenem resistant Klebsiella pneumoniae (CRKP) in
a 700 bed capacity general hospital in Kano, Nigeria.
CRPK infections are very difficult to treat. Colistin is
one of reserved antibiotics for treating CRPKs. Of
recent, invitro colistin resistant strains of CRKP were
detected by disc diffusion method using 10 μg colistin
discs (Oxoid, UK) according to the CLSI guidelines.
Objectives
To test the susceptibility of CRKP invitro to colistin and
screen the colistin resistant isolates for extended spectrum
beta-lactamase (ESBL), AmpC and Metallo beta lactamase
(MBL) production.
Methods
Susceptibility of 34 CRPK to colistin was determined
using disc diffusion method. Colistin resistant strains
were concurrently screened phenotypically for ESBL and
MBL according to CLS1 2012 breakpoints using double
disk synergy test and modified Hodge test respectively.
AmpC was detected using AmpC disk test.
Results
Result shows that 6 out of 34 CRPKs (17.6%) were resistant
to colistin (Interpretative criteria: resistant ≤ 11mm). Five
CRPK produced ESBL and AmpC, and 3 produced MBL
type of carbapenemase. Co-production of ESBL and AmpC
was detected in 4 of the isolates, ESBL and MBL in 3,
AmpC and MBL in 2. ESBL, AmpC and MBLs were
detected concurrently in 3 CRPK. Five out of the 6 CRKP
(83.3%) were isolated from urine and cathertips, while the
remaining one was from wound.
Conclusion
The study indicates that, colistin resistant CRPK strains
have emerged in the hospital. Co-production of two or
three of the beta lactamase enzymes by many of the iso-
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